Ardigen
Dr. Michał Warchoł focuses on the development and applications of computer vision algorithms accelerating the drug discovery process. Michał joined Ardigen in 2016 to build Data Science and Machine learning capabilities and expertise within Ardigen AI Labs. Currently, Michal is a General Director of a Biomedical Imaging Business Unit that strives to improve both, clinical and preclinical stages of the drug discovery process, by leveraging information contained in images. Michal did a PhD in Statistics at the Institute of Statistics, Biostatistics and Actuarial Sciences at Université Catholique de Louvain in Belgium. Part of his research program was conducted at the Department of Statistics at Columbia University in New York. Prior to joining Ardigen, Dr. Warchoł co-founded DeepArt UG, a company providing novel image processing algorithms based on deep learning.
This person is not in any teams
This person is not in any offices
Ardigen
3 followers
Ardigen, a world-leading AI CRO, stands at the forefront of enabling AI transformation for the biotech and pharmaceutical sectors. Our objective is to increase the probability of success in the drug development process. We utilize our advanced platforms and deep expertise to turn vast amounts of data into pivotal, ready-to-use scientific insights. Leveraging our expertise, we also enhance the infrastructure that allows our clients to integrate and utilize these capabilities seamlessly within their organizations.